Kaiser Health News: Drug Trade Group Quietly Spends ‘Dark Money’ To Sway Policy And Voters
PhRMA was one of AAN’s biggest donors the previous year, giving it $6.1 million, federal regulatory findings show
PhRMA was one of AAN’s biggest donors the previous year, giving it $6.1 million, federal regulatory findings show
Though drug makers continue to raise prices out of proportion to increases in value, PBMs are doing their job by keeping drug costs down
Even including discounts, however, the company’s net profit margin for 2017 was 34 percent, its highest since at least 2000, when it was half that high.
This practice, the HHS inspector general said, could harm patients, the government and taxpayers because people might take pricey drugs instead of cheaper ones.
PCMA said the changes wouldn’t be as disruptive as others argued, and highlighted several classes of drugs
Pharmaceutical companies gave at least $116 million to patient advocacy groups in a single year
Mark Merritt said “we always support, as an industry, patients paying lower price at the counter…it’s an outlier practice.”
Greater competition is the answer, Mr. Merritt said, and he praised recent efforts by the Food and Drug Administration
©2024 PCMA. All Rights Reserved.